Quick Takeaways
- Todd C. Brady has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,487,459.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Todd C. Brady
- Location
- Solana Beach, CA
- Summary
- The estimated net worth of Todd C. Brady is at least $4,487,459 dollars as of 31 Mar 2026. Todd C. Brady is the President and CEO, Director of Aldeyra Therapeutics, Inc. and owns shares of Aldeyra Therapeutics, Inc. (ALDX) stock worth about $4.49M.
- Signature
- /s/ Todd C. Brady
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Todd C. Brady and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Aldeyra Therapeutics, Inc. ($4,487,459).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Todd C. Brady
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | President and CEO, Director | $4,487,459 | 27 Mar 2026 | ||
| EVOK | Evoke Pharma Inc | Director | $0 | 16 Dec 2025 | ||
| FSTX | F-star Therapeutics, Inc. | Director | 17 Jun 2022 |
Insider Transactions Reported by Todd C. Brady:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.